Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Antibody 130

Antibody DNA Development Vaccination 130

pharmaphorum

MARCH 23, 2022

Vyvgart (efgartigimod alfa) became the first drug in the FcRn class to be approved by the FDA last December, and despite a $225,000 annual price tag is predicted to make relatively modest sales in its IV version, which will compete with other IV gMG drugs like AstraZeneca/Alexion’s C5 inhibitor Soliris (eculizumab).

Antibody 52

Antibody Sales FDA Approval Trials 52

pharmaphorum

NOVEMBER 24, 2022

Johnson & Johnson’s Spravato therapy for treatment-resistant depression (TRD) hasn’t made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate its take-up.

Trials 52

Trials Sales Drugs Marketing 52

Rethinking Clinical Trials

FEBRUARY 20, 2024

Chair in General Internal Medicine Rutgers, Robert Wood Johnson Medical School Keywords Transfusion; MI; MINT; Anemia; Clinical trials Key Points Anemia is common in patients with acute MI. Reynolds, M.D. Due to the lack of evidence, indications for red blood cell transfusion in patients with MI are controversial.

Trials 130

Trials Clinical Trials Clinical Trials Medicine 130

pharmaphorum

JULY 25, 2022

The EMA’s human medicines committee has recommended approval of Johnson & Johnson’s Tecvayli as a fourth-line therapy for multiple myeloma , joining a growing group of BCMA-targeted therapies for the blood cancer.

Antibody 52

Antibody Medicine Drugs Trials 52

pharmaphorum

JUNE 2, 2022

Evaluate expects five big pharma companies to be reliant on orphan drugs to provide 20% or more of their sales by 2026, with Johnson & Johnson topping the list at an estimated 39% of all sales. By 2026, this would mean that orphan drug sales will account for 20% of all prescription drug sales. Raising questions.

Drugs 52

Drugs Sales Marketing Development 52

pharmaphorum

FEBRUARY 26, 2021

By most measures the single largest pharma company in the world, US-based Johnson & Johnson (J&J) is also arguably one of the most well-known drugmakers among the general public. . Johnson & Johnson was founded over 125 years ago in the year 1886. Where it all began.

Sales 126

Sales Production Pharma Companies Marketing 126

pharmaphorum

SEPTEMBER 29, 2021

If you need to phrase your message off-business hours, tag your draft for later delivery and release it during office hours. Most recently he was Johnson & Johnson’s global head of external innovation communication. The signal conveyed is for them to feel guilty if they cannot react instantly at 3 am on Sunday morning.

Life Science 119

Life Science Containment Sales Marketing 119

pharmaphorum

MARCH 27, 2022

Johnson & Johnson is in course for approval of its multiple myeloma CAR-T therapy Carvykti in the EU the next few weeks, after getting a green light from the EMA’s human medicines committee. In the US, Abecma has a list price of around $420,00, while J&J has set its therapy a little higher at $465,000.

Antibody 98

Antibody Clinical Trials Clinical Trials Sales 98

XTalks

MARCH 22, 2023

In 2006, Pfizer sold its consumer arm to Johnson & Johnson before merging with fellow US-based drugmaker Wyeth in 2009 in a mammoth $68 billion deal. In addition, nearly half of all new drugs launched between 2020 and 2021 came with a price tag of $150,000 per year, or more.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

XTalks

DECEMBER 21, 2022

The multi-million-dollar price tags are largely attributable to the high R&D and manufacturing costs associated with making a gene therapy, as the raw materials for producing the therapy can be expensive. Currently, CSL Behring’s one-dose Hemophilia B gene therapy Hemgenix holds the title at $3.5 million for a single infusion.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52